PHARMACOKINETICS OF DOXORUBICIN FOLLOWING INTRAPERITONEAL ADMINISTRATION IN THE FREE FORM OR IN LIPOSOMES

被引：0
|
作者：
WIERNIKOWSKI, JT [1 ]
CIMINO, MA [1 ]
MAYHEW, E [1 ]
ARBUCK, SG [1 ]
机构：
[1] NEW YORK STATE DEPT HLTH,ROSWELL PK MEM INST,BUFFALO,NY 14263
来源：
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH | 1988年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：509 / 509
页数：1
相关论文
共 50 条
  • [31] EPIRUBICIN PHARMACOKINETICS AFTER INTRAHEPATIC ARTERIAL AND INTRAPERITONEAL ADMINISTRATION
    STROCCHI, E
    CAMAGGI, CM
    ROSSI, AP
    ANGELELLI, B
    COMPARSI, R
    FRANCHINI, A
    DELPRETE, P
    COLA, B
    PANNUTI, F
    DRUGS UNDER EXPERIMENTAL AND CLINICAL RESEARCH, 1985, 11 (04) : 295 - 301
  • [32] Effect of repetitive administration of doxorubicin-containing liposomes on plasma pharmacokinetics and drug biodistribution in a rat brain tumor model
    Arnold, RD
    Mager, DE
    Slack, JE
    Straubinger, RM
    CLINICAL CANCER RESEARCH, 2005, 11 (24) : 8856 - 8865
  • [33] Doxorubicin cardiomyopathy in rats: Comparison of the intraperitoneal and intravenous administration routes
    Lasocki, S
    Escoubet, B
    Certain, E
    Heimburger, M
    Massias, L
    Mercadier, JJ
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2001, 33 (06) : A65 - A65
  • [34] Hyperthermic intraperitoneal doxorubicin: pharmacokinetics, metabolism, and tissue distribution in a rat model
    Jacquet, P
    Averbach, A
    Stuart, OA
    Chang, D
    Sugarbaker, PH
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1998, 41 (02) : 147 - 154
  • [35] Pharmacokinetics of the intraperitoneal nanoparticle pegylated liposomal doxorubicin in patients with peritoneal metastases
    Sugarbaker, Paul H.
    Stuart, O. Anthony
    EJSO, 2021, 47 (01): : 108 - 114
  • [36] ACTIVATION OF FC RECEPTOR-MEDIATED PHAGOCYTOSIS BY MOUSE PERITONEAL-MACROPHAGES FOLLOWING THE INTRAPERITONEAL ADMINISTRATION OF LIPOSOMES
    ARAMAKI, Y
    MURAI, M
    TSUCHIYA, S
    PHARMACEUTICAL RESEARCH, 1994, 11 (04) : 518 - 521
  • [37] Hyperthermic intraperitoneal doxorubicin: Pharmacokinetics, metabolism, and tissue distribution in a rat model
    Jacquet P.
    Averbach A.
    Stuart O.A.
    Chang D.
    Sugarbaker P.H.
    Cancer Chemotherapy and Pharmacology, 1997, 41 (2) : 147 - 154
  • [38] IMMUNOTOXICITY OF MULTIPLE DOSING REGIMENS OF FREE DOXORUBICIN AND DOXORUBICIN ENTRAPPED IN CARDIOLIPIN LIPOSOMES
    RAHMAN, A
    JOHER, A
    NEEFE, JR
    BRITISH JOURNAL OF CANCER, 1986, 54 (03) : 401 - 408
  • [39] REDUCTION IN CHRONIC CARDIOTOXICITY AFTER ADMINISTRATION OF DOXORUBICIN ENCAPSULATED IN LIPOSOMES
    HERMAN, E
    FERRANS, V
    VICK, J
    RAHMAN, A
    SCHEIN, P
    CLINICAL RESEARCH, 1982, 30 (02): : A632 - A632
  • [40] URTICARIA FOLLOWING INTRAVENOUS DOXORUBICIN ADMINISTRATION
    SOUHAMI, L
    FELD, R
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1978, 240 (15): : 1624 - 1626
12345